Pfizer to close Irish Plant
This article was originally published in Scrip
Executive Summary
Pfizer is closing its Little Island manufacturing plant in Cork, part of the latest phase of its restructuring plans in Ireland. The site, which currently employs 136 people, will shut before the end of next year. According to the company, the decision is based on a "global effort to align manufacturing capacity", related to the expiration of key patents and the need to find more efficiencies in production. Work from the site will move to one of Pfizer's other Irish plants in Ringaskiddy. Vice-president Paul Duffy, said the country remains a key strategic location for the New York-based company, "with extensive operations in Cork, Kildare and Dublin [ongoing]". Currently, Pfizer employs more than 3,200 people across six sites in the country.